Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines

Comparative Benefits and Risks Associated with Currently Authorized COVID-19 Vaccines

This article provides a systematic assessment of the efficacy, risks, and methodological quality of evidence from five major publicly available vaccine trials. Results from Pfizer-BioNTech mRNA, Moderna-US NIH mRN-1273, AstraZeneca-Oxford ChAdOx1 nCov-19, Gamaleya GamCovidVac (Sputnik V), and Ad26.C...

Full description

Bibliographic Details
Main Authors: Jacob R. Albers, Jeffrey B. Brown, Shaun V. Charkowick, Natasha Ram, Farina A. Klocksieben, Ambuj Kumar
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
COVID
vaccines
grade
evidence
transparency
Online Access:https://www.mdpi.com/2076-393X/10/12/2065

Internet

https://www.mdpi.com/2076-393X/10/12/2065

Similar Items